Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|7|1|3-13

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.7, Iss.1, 2012-01, pp. : 3-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-116

Bentham Science Publishers

Access to resources Recommend Favorite

Management of transitional cell carcinoma by targeting the epidermal growth factor receptor

By Brook Nicholas R   Colquhoun Alex J   Mellon J Kilian  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 407-416

Future Medicine

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: Advances and Controversies

By  

Oncology, Vol. 70, Iss. 3, 2006-07 ,pp. : 161-167

Karger

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta‐analysis

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 5, 2015-11 ,pp. : 310-322

John Wiley & Sons Inc

Access to resources Recommend Favorite